Global Gel Column Agglutination Test System Market, Trends Size, By Test Type (Antibody Screening, Serology Test, DAT, and Others), By Type (Portable, Bench-Top), By End-User (Pharmaceuticals Industry, Hospital Blood Banks, and Diagnostic Center), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Gel Column Agglutination Test System Market
The Global Gel Column Agglutination Test System Market was valued at US$ 3.4 Mn in 2022, estimated to reach US$ 5.3 Mn by 2030, with a CAGR of 3.90% from 2023-2030.
The gel column agglutination test system uses automated technology to separate agglutinated red blood cells during centrifugation using the gel column as a filter. These systems are employed by the pharmaceutical and diagnostic industries.
Market Drivers
A few of the factors influencing the overall market are the population's high health awareness and the government's high health spending. The high accuracy and quicker findings of the gel column agglutination test will encourage more people to use them and drive the market's revenue growth. In the pharmaceutical sector, these tests are frequently employed for diagnostic purposes. The market is also being driven by several applications in the field of research laboratories. These tests are straightforward to perform, and the basic principle is used to separate agglutinated blood from non-agglutinated red blood cells using a gel column based on size, which has led to a high demand for these systems in laboratories. Additionally, technological developments and an increase in diagnostic facilities are anticipated to propel the market growth.
Market Restraints
The fact that the responses are, at best, semi-quantitative is one of the main drawbacks of agglutination procedures. Even while qualitative test results are generally reproducible, the results are often only accurate to a fourfold difference in antibody titer for most test systems. Another significant drawback of agglutination techniques is that they are susceptible to erroneous negative reactions brought on by the prozone phenomenon. In situations of excessive antibody excess, prozone is the absence of agglutination, which leads to inadequate lattice formation.
Market Segmentation
The scope of the Global Gel Column Agglutination Test System Market covers segmentation based on Test Type, Type, End User, and Region.
Based on Test Type, the market is segmented into Antibody Screening, Serology Test, DAT, and Others.
Based on Type, the market is divided into Portable, Bench-Top.
Based on End-User, the market is classified into Pharmaceuticals Industry, Hospital Blood Banks, and Diagnostic Centers.
Regional Analysis
The Global Gel Column Agglutination Test System Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Because of the expanding number of diagnostic facilities and the high level of health consciousness in this region, North America is anticipated to account for a sizable portion of global sales of gel-column agglutination test systems. Additionally, the use of these testing methods is growing due to technological developments in the gel column agglutination testing system, which is helping it to dominate the market in this area. The expansion of the regional market as a whole is also being greatly aided by rising healthcare spending as well as the presence of an established healthcare infrastructure.
Key Players
Cadila Healthcare Limited, Hikma Pharmaceuticals PLC, IPCA Laboratories Ltd, Mylan N.V, Novartis International AG, Pfizer Inc, Sanofi S.A, Taj Pharma Group, Teva Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Limited
Market Taxonomy
By Test Type
• Antibody Screening
• Serology Test
• DAT
• Others
By Type
• Portable
• Bench-Top
By End-User
• Pharmaceuticals Industry
• Hospital Blood Banks
• Diagnostic Center
By Drug Activity
• Anti-Malarial Drug
• Anti-Rheumatic Drug
• Lupus Suppressant Drug
• Anti COVID-19 Drug
• Other Drug Activity
By Formulation
• Tablets
• Injection
By Application
• Malaria
• Rheumatoid Arthritis
• Lupus Erythematosus
• COVID-19
• Other Applications
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
Global Gel Column Agglutination Test System Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Gel Column Agglutination Test System Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Gel Column Agglutination Test System Market, By Test Type
5.1 Y-o-Y Growth Comparison, By Test Type
5.2 Global Gel Column Agglutination Test System Market Share Analysis, By Test Type
5.3 Global Gel Column Agglutination Test System Market Size and Forecast, By Test Type
5.3.1 Anti-Malarial Drug
5.3.2 Anti-Rheumatic Drug
5.3.3 Lupus Suppressant Drug
5.3.4 Anti COVID-19 Drug
5.3.5 Other Test Type
6 Global Gel Column Agglutination Test System Market, By Type
6.1 Y-o-Y Growth Comparison, By Type
6.2 Global Gel Column Agglutination Test System Market Share Analysis, By Type
6.3 Global Gel Column Agglutination Test System Market Size and Forecast, By Type
6.3.1 Tablets and Injection
6.3.2 Injection
Surgical Instruments Market, By End-User
7.1 Y-o-Y Growth Comparison, By End-User
7.2 Global Gel Column Agglutination Test System Market Share Analysis, By End-User
7.3 Global Gel Column Agglutination Test System Market Size and Forecast, By End-User
7.3.1 Malaria
7.3.2 Rheumatoid Arthritis
7.3.3 Lupus Erythematosus
7.3.4 COVID-19
7.3.5 Other Applications
8 Global Gel Column Agglutination Test System Market, By Region
8.1 Global Gel Column Agglutination Test System Market Share Analysis, By Region
8.2 Global Gel Column Agglutination Test System Market Size and Forecast, By Region
8.3 Global Gel Column Agglutination Test System Market Trends and Forecast, By Region
9 North America Gel Column Agglutination Test System Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Gel Column Agglutination Test System Market Share Analysis, By Test Type
9.3 North America Gel Column Agglutination Test System Market Size and Forecast, By Type
9.4 North America Gel Column Agglutination Test System Market Size and Forecast, By End-User
9.5 North America Gel Column Agglutination Test System Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Test Type
9.5.1.2 Market Size and Forecast, By Type
9.5.1.3 Market Size and Forecast, By End-User
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Test Type
9.5.2.2 Market Size and Forecast, By Type
9.5.2.3 Market Size and Forecast, By End-User
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Test Type
9.5.3.2 Market Size and Forecast, By Type
9.5.3.3 Market Size and Forecast, By End-User
10 Europe Gel Column Agglutination Test System Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Gel Column Agglutination Test System Market Share Analysis, By Test Type
10.3 Europe Gel Column Agglutination Test System Market Size and Forecast, By Type
10.4 Europe Gel Column Agglutination Test System Market Size and Forecast, By End-User
10.5 Europe Gel Column Agglutination Test System Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Test Type
10.5.1.2 Market Size and Forecast, By Type
10.5.1.3 Market Size and Forecast, By End-User
10.5.2 France
10.5.2.1 Market Size and Forecast, By Test Type
10.5.2.2 Market Size and Forecast, By Type
10.5.2.3 Market Size and Forecast, By End-User
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Test Type
10.5.3.2 Market Size and Forecast, By Type
10.5.3.3 Market Size and Forecast, By End-User
10.5.4. Russia
10.5.4.1 Market Size and Forecast, By Test Type
10.5.4.2 Market Size and Forecast, By Type
10.5.4.3 Market Size and Forecast, By End-User
10.5.5. Italy
10.5.5.1 Market Size and Forecast, By Test Type
10.5.5.2 Market Size and Forecast, By Type
10.5.5.3 Market Size and Forecast, By End-User
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Test Type
10.5.6.2 Market Size and Forecast, By Type
10.5.6.3 Market Size and Forecast, By End-User
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Test Type
10.5.7.2 Market Size and Forecast, By Type
10.5.7.3 Market Size and Forecast, By End-User
11 Asia Pacific Gel Column Agglutination Test System Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Gel Column Agglutination Test System Market Share Analysis, By Test Type
11.3 Asia Pacific Gel Column Agglutination Test System Market Size and Forecast, By Type
11.4 Asia Pacific Gel Column Agglutination Test System Market Size and Forecast, By End-User
11.5 Asia Pacific Gel Column Agglutination Test System Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Test Type
11.5.1.2 Market Size and Forecast, By Type
11.5.1.3 Market Size and Forecast, By End-User
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Test Type
11.5.2.2 Market Size and Forecast, By Type
11.5.2.3 Market Size and Forecast, By End-User
11.5.3 India
11.5.3.1 Market Size and Forecast, By Test Type
11.5.3.2 Market Size and Forecast, By Type
11.5.3.3 Market Size and Forecast, By End-User
11.5.4. South Korea
11.5.4.1 Market Size and Forecast, By Test Type
11.5.4.2 Market Size and Forecast, By Type
11.5.4.3 Market Size and Forecast, By End-User
11.5.5. Australia
11.5.5.1 Market Size and Forecast, By Test Type
11.5.5.2 Market Size and Forecast, By Type
11.5.5.3 Market Size and Forecast, By End-User
11.5.6. New Zealand
11.5.6.1 Market Size and Forecast, By Test Type
11.5.6.2 Market Size and Forecast, By Type
11.5.6.3 Market Size and Forecast, By End-User
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Test Type
11.5.7.2 Market Size and Forecast, By Type
11.5.7.3 Market Size and Forecast, By End-User
11.5.8. Malaysia
11.5.8.1 Market Size and Forecast, By Test Type
11.5.8.2 Market Size and Forecast, By Type
11.5.8.3 Market Size and Forecast, By End-User
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Test Type
11.5.9.2 Market Size and Forecast, By Type
11.5.9.3 Market Size and Forecast, By End-User
12 Latin America Gel Column Agglutination Test System Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Gel Column Agglutination Test System Market Share Analysis, By Test Type
12.3 Latin America Gel Column Agglutination Test System Market Size and Forecast, By Type
12.4 Latin America Gel Column Agglutination Test System Market Size and Forecast, By End-User
12.5 Latin America Gel Column Agglutination Test System Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Test Type
12.5.1.2 Market Size and Forecast, By Type
12.5.1.3 Market Size and Forecast, By End-User
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Test Type
12.5.2.2 Market Size and Forecast, By Type
12.5.2.3 Market Size and Forecast, By End-User
12.5.3. Colombia
12.5.3.1 Market Size and Forecast, By Test Type
12.5.3.2 Market Size and Forecast, By Type
12.5.3.3 Market Size and Forecast, By End-User
12.5.4. Peru
12.5.4.1 Market Size and Forecast, By Test Type
12.5.4.2 Market Size and Forecast, By Type
12.5.4.3 Market Size and Forecast, By End-User
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Test Type
12.5.5.2 Market Size and Forecast, By Type
12.5.5.3 Market Size and Forecast, By End-User
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Test Type
12.5.6.2 Market Size and Forecast, By Type
12.5.6.3 Market Size and Forecast, By End-User
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Test Type
12.5.7.2 Market Size and Forecast, By Type
12.5.7.3 Market Size and Forecast, By End-User
13 Middle East Gel Column Agglutination Test System Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Gel Column Agglutination Test System Market Share Analysis, By Test Type
13.3 Middle East Gel Column Agglutination Test System Market Size and Forecast, By Type
13.4 Middle East Gel Column Agglutination Test System Market Size and Forecast, By End-User
13.5 Middle East Gel Column Agglutination Test System Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Test Type
13.5.1.2 Market Size and Forecast, By Type
13.5.1.3 Market Size and Forecast, By End-User
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Test Type
13.5.2.2 Market Size and Forecast, By Type
13.5.2.3 Market Size and Forecast, By End-User
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Test Type
13.5.3.2 Market Size and Forecast, By Type
13.5.3.3 Market Size and Forecast, By End-User
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By End-User
13.5.4.2 Market Size and Forecast, By Type
13.5.4.3 Market Size and Forecast, By End-User
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Test Type
13.5.5.2 Market Size and Forecast, By Type
13.5.5.3 Market Size and Forecast, By End-User
13.5.5 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Test Type
13.5.6.2 Market Size and Forecast, By Type
13.5.6.3 Market Size and Forecast, By Test Type-
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Bio-Rad Laboratories, Inc.
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Grifols
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 QIAGEN
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Ortho Clinical Diagnostics
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Tulip Diagnostics (P) Ltd
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Thermo Fisher Scientific
1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 3B scientific
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Mira Vista Labs
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
